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Background: Cytoadherence of Plasmodium falciparum-infected erythrocytes (IEs) in deep microvasculature
endothelia plays a major role in the pathogenesis of cerebral malaria (CM). This biological process is thought to
be mediated by P. falciparum erythrocyte membrane protein-1 (PfEMP-1) and human receptors such as CD36
and ICAM-1. The relationship between the expression of PfEMP-1 variants and cytoadherence phenotype in the
pathology of malaria is not well established.
Methods: Cytoadherence phenotypes of IEs to CD36, ICAM-1, CSPG and the transcription patterns of A, B, var2csa,
var3, var gene groups and domain cassettes DC8 and DC13 were assessed in parasites from children with CM and
uncomplicated malaria (UM) to determine if cytoadherence is related to a specific transcription profile of pfemp-1
variants.
Results: Parasites from CM patients bind significantly more to CD36 than those from UM patients, but no
difference was observed in their binding ability to ICAM-1 and CSPG. CM isolates highly transcribed groups A, B,
var2csa, var3, DC8 and DC13 compared to UM parasites. The high transcription levels of var genes belonging to
group B positively correlated with increased binding level to CD36.
Conclusion: CM isolates bind significantly more to CD36 than to ICAM-1, which was correlated with high transcription
level of group B var genes, supporting their implication in malaria pathogenesis.
Keywords: Plasmodium falciparum, Cerebral malaria, Uncomplicated malaria, Var genes, Domain cassette, Transcript
abundance, Cytoadherence, CD36, ICAM-1, CSPG, CSABackground
Cerebral malaria (CM) is one of the serious manifesta-
tions of falciparum malaria. Despite an adequate treat-
ment, 15-20% of infants presenting with CM die in
hospital [1]. There is strong evidence that sequestration
of Plasmodium falciparum-infected erythrocytes (IEs)
within the brain microvascular endothelia plays a key* Correspondence: Rachida.Tahar@ird.fr
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unless otherwise stated.role in CM pathogenesis [2,3]. This and comparable in
CM and UM isolates. Howeverphenomenon protects the
mature parasites from spleen-dependent clearance [4].
The adhesive properties of IEs are attributed to P.
falciparum Erythrocyte Membrane Protein-1 (PfEMP-1)
expressed at the surface of IEs [5]. Encoded by ~60 mem-
bers of var gene family, pfemp-1 genes are divided into
three main groups (A, B and C) and three relatively
conserved groups var1, var2csa and var3 [6]. It has
been shown that groups A and B var genes are differ-
entially transcribed in isolates associated with severe
malaria, compared with parasites from uncomplicated
malaria (UM) or asymptomatic infections [7-9]. RecentLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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by 23 conserved architectural motifs named domain
cassettes (DC) and that DC8 and DC13 are of clinical
significance. The transcription levels of these DCs
are higher in parasites from severe malaria, including
CM, than in those from UM [10,11]. Moreover, P.
falciparum parasites selected for binding to human brain
microvascular endothelial cells (HBMEC) express high
levels PfEMP-1 DC8 genes [12], and plasma from convales-
cent patients exhibited higher antibody recognition profiles
to HBMEC-selected parasites than unselected ones, sug-
gesting the importance of PfEMP-1 motifs in building pro-
tective immunity to malaria [12,13].
In vitro experiments identified a few endothelial
receptors that participate in the adherence of IEs to
microvasculature endothelia. CD36 and Inter Cellular
Adhesion Molecule-1 (ICAM-1) are the most commonly
used receptors by clinical isolates [14]. As yet, apart from
chondroitin sulphate A proteoglycan (CSPG), which is the
main receptor of parasites isolated from pregnant women,
no definite candidate has been determined for cerebral
malaria pathology [15]. It has been shown that parasites
infecting children or non-pregnant host have very low
binding to CSA, suggesting a role of other receptors in the
pathology of malaria in non pregnant women [16,17].
CD36 is considered as a common receptor involved in the
cytoadherence of P. falciparum isolates [18-20]. Several
studies have found no difference in CD36-binding pat-
terns between parasites from severe malaria and those
from UM patients [17,21], while others have reported
an association between UM and high binding level to
CD36 [22,23]. Post-mortem brain examination has re-
ported high levels of ICAM-1, which co-localized with
IEs in cerebral blood vessels [24]. This finding is in
agreement with studies that suggested an association
between disease severity and ICAM-1-binding [23].
However, some studies did not detect any difference in
binding to ICAM-1 in parasite isolates from severe or
mild cases [20,25].
The involvement of CD36 and ICAM-1 as well as that
of PfEMP-1 variant expression in the pathogenesis of
CM has not been well established. Recently, Turner et al
identified the Endothelial Protein C Receptor (EPCR) as
a new mediator of IEs adhesion to microvascular endo-
thelial cells via the interaction with domain cassette 8
and 13 of PfEMP-1 variants.
To investigate the relationship between PfEMP-1
variant expression and cytoadhesion to CD36, ICAM-1
and CSPG the binding phenotype as well as the
transcript abundance of pfemp-1 variants of parasites
freshly collected from Beninese children with CM or
UM was carried out by static binding assay and rt-
qPCR respectively. The binding assay to EPCR was not
investigated in this study.Methods
Ethics statement
This study was reviewed and approved by the ethics com-
mittee of the Research Institute of Applied Biomedical
Sciences, Cotonou, Benin (No 006/CER/ISBA/12 and No
21/CER/ISBA/13).Study design, malaria patients
This study was conducted in Cotonou, southern Benin,
during the 2012 and 2013 malaria transmission periods
(June-September and May-July, respectively). This area
is characterized by two rainy seasons during which malaria
infection is mainly caused by P. falciparum, with approxi-
mately 33 infective bites per person annually [26].
Children under five years of age spontaneously presenting
at Hôpital Mère-enfant de la Lagune (HOMEL), Centre
National Hospitalier Universitaire Hubert Koutoucou
Mega (CNHU-HKM), or to Hôpital Suru-Léré were
screened by rapid diagnostic test for malaria (DiaQuick
Malaria P. falciparum Cassette, Dialab®; Hondastrasse,
Austria) and were recruited in the study if they pre-
sented CM or UM. CM was defined as a microscopic-
ally confirmed P. falciparum infection and a Blantyre
coma score ≤2, with the exclusion of any other causes
of coma. UM was defined as P. falciparum parasitaemia ac-
companied by fever, headache, or myalgia without signs of
severity and/or evidence of vital organ dysfunction, as de-
fined by the World Health Organization (WHO) [27]. After
obtaining informed and written consent from parents or
guardians, 2 to 4 ml of venous blood samples were col-
lected into tubes containing citrate phosphate dextrose ad-
enine. Plasmodium falciparum infections were confirmed
by microscopic examination of Giemsa-stained thick blood
smears, and parasitaemia was recorded as the number of
asexual parasites/μL of blood. All participants were treated
according to the guidelines established by the Beninese
Ministry of Health.Sample preparation and parasite culture
Plasma and buffy coat were removed from fresh parasit-
ized blood samples, and red cell pellet was washed twice
in RPMI 1640 medium (LONZA, Amboise, France) con-
taining 50 mg/ml gentamicin by centrifugation (800 g ×
10 min). One-hundred μl were conserved in TRIzol®
reagent (Life Technologies, Illkirch, France), and stored
at -80°C for RNA extraction. Another 100 μl were spot-
ted on Whatman 3MM filter paper, and stored at room
temperature for DNA extraction and merozoite surface
protein-1 (msp-1) and msp-2 genotyping. Five-hundred
μl were cultured in RPMI 1640 medium supplemented
with 10% human serum. Parasites were cultured for less
than 48 hours until they reached the mature stage
(mature trophozoites and schizonts) and purified using
Almelli et al. Malaria Journal 2014, 13:333 Page 3 of 9
http://www.malariajournal.com/content/13/1/333magnetic columns (MACS, Milteny Biotec, Bergisch
Gladbach, Germany) for binding assay.
Binding assay
Static binding assays were performed with 27 UM and
38 CM fresh isolates at 20% parasitaemia in 100 × 15-
mm Petri dishes as described [28]. Twenty μl of each re-
combinant protein diluted in phosphate buffer saline
(PBS) were spotted on Petri dish and incubated overnight
at 4°C in a sealed humid container. The following recom-
binant proteins were used: CSPG at 5 μg/ml (Decorin,
Sigma-Aldrich, Saint-Quentin Fallavier, France), CD36 and
ICAM-I at 10 μg/ml (R&D, Lille, France). The spots were
blocked with 3% bovine serum albumin (BSA) in PBS for
30 min at 37°C in a humid chamber. Purified parasites were
washed with PBS, centrifuged for 10 min at 800 g, resus-
pended in 3% BSA in RPMI 1640 medium and 20 μl of
parasite suspension were added to each spot and incubated
for 12 min at room temperature. Unbound erythrocytes
were washed off gently with PBS using an automated wash-
ing system. Bound cells were fixed with 1.5% glutaraldehyde
in PBS for 10 min, Giemsa-stained and counted microscop-
ically. The number of IEs bound to each receptor was de-
termined by counting ten fields using a 40× objective, and
expressed as the number of IEs bound per sq mm. For each
sample, the binding assay was done in duplicate for all pro-
teins in the same plate. Results were expressed as the mean
binding level of duplicate spots per sample. As a negative
control, 1% BSA was used to assess non-specific binding.
This protocol has been standardized using FCR3-CSA and
FCR3-CD36 binding parasite strains.
As documented in several studies CSA binding
phenotype is highly correlated with the expression of
VAR2CSA in IEs from pregnant women [29-31]. There-
fore, CSA binding experiment and var2csa transcript
abundance assessment as a second negative control were
included. The binding to CSA and transcription of
var2csa in parasite from children are expected to be low
or undetectable.
Parasite RNA extraction and cDNA synthesis
cDNAs were synthesized from 36 UM and 51 CM samples
preserved in TRIzol® reagent, following the manufacturer’s
instructions. RNAs were treated with DNAse I (BioLabs,
Ipswich, MA), and the absence of genomic DNA was
assessed by 40 cycles of RT-PCR with fructose-biphosphate
aldolase primers [29]. Reverse transcription of RNA was
performed by Thermoscript® (Life Technologies) with ran-
dom hexamers and oligo dt primers, following manufac-
turer’s recommendations.
Transcript abundance level of var genes
Individual RT-PCR reactions were performed using Rotor-
gene® thermal cycler (Corbett Research) with 1X SYBRGreen® (Bioline) and 1.25 μM of specific primer pairs for
group A (A1, A2, A3), group B (B1), var2csa and var3 of
var genes. A set of primers that target DC8 and DC13 was
also used [10]. The endogenous controls used were fruc-
tose-bisphosphate aldolase and seryl-tRNA synthetase [29].
Cycling conditions were 95°C for 1 min, followed by 40 cy-
cles of 95°C for 30 sec, 54°C for 40 sec, and 68°C for 50 sec.
Data were analysed by the Rotorgene software for which
the threshold cycle was set at 0.025. The specificity of each
PCR product was verified by the specific melting curve for
each pair of primers. The transcript abundance was calcu-
lated by relative quantification using two housekeeping
genes (ΔCt var_primer = Ct vr_primer - Ct average_control primers).
Transcript units were determined as Tu = 2(5-ΔCt) [10].
Genomic DNA extraction and msp1 and msp2 genotyping
Genomic DNA was extracted from filter papers using
the Chelex 100 resin method [32]. Specific primers were
used to amplify block 2 of msp-1 and block 3 of msp-2
[33]. Multiplicity of infection (MOI) was defined as the
highest msp-1 or msp-2 allele number found in each
sample.
Statistical analysis
Binding data were expressed as the number of IEs/mm2
bound to a given receptor minus the number of IEs
bound to BSA. The non-parametric Mann-Whitney U
test was used to compare the binding levels to receptors
and the transcript abundance of var group genes and
DC8 and DC13 between CM and UM groups. Correl-
ation coefficient between binding profile and transcript
level of dominant var group, which was transcribed in
more than 50% of samples, was calculated by the Spear-
man’s rank test. Data were plotted and statistical tests
were performed using Prism v5 software (GraphPad
Software, Inc., San Diego, CA, USA). The level of statis-
tical significance was set at 0.05.
Results
A total of 88 children were enrolled, including 52 chil-
dren with CM and 36 with UM. Of 52 children with
CM, 21 presented CM alone, while the others had over-
lapping clinical syndromes: 25 with severe anaemia (SA),
and 16 with hyperparasitaemia (HP) defined as parasite
density ≥250.000 p/μl (ten children with CM presented
both SA and HP). The clinical and biological features of
these patients are summarized in Table 1. There was no
difference (P >0.05) in the mean age, sex ratios and
mean body temperature between the two groups. How-
ever, the mean haemoglobin level was lower (P <0.0001),
while the mean parasite density was higher (P <0.01) in
CM group than UM group. All children with UM sur-
vived, while 19 patients (36.5%) with CM died. Multiple
infections were recorded in both groups, with a mean
Table 1 Parasitological and clinical characteristics of
children enrolled in Cotonou, 2012-2013
Cerebral
malaria
(N = 52)
Uncomplicated
malaria (N = 36)
P-value
Sex ratio (female/male) 23/29 18/18 0.2
Age (months),
median [range]
42 [5-72] 33 [8-58] 0.09
Parasitaemia (P/μl),
median [range]
75,806 [889-
3,600,000]
49,453.5
[1,164-246,857]
0.01
Haemoglobin (g/dl),
median [range]
5.15 [0.8-12.6] 7.45 [5.2-12.5] 0.0001
Blantyre score,
median [range]
2 [0-2] - -
Temperature,
median [range]
38°C [35.5-40°
C]
38.5°C
[36.5-40°C]
0.15
Multiplicity of infection,
median [range]
3.4 [1-6] 2.2 [1-6] 0.0001
Number of deaths 19 0 -
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parasite populations in UM group (P <0.0001), These
MOI values are consistent with the high endemicity of
malaria in the study site.Binding profiles
Due to the low parasitaemia of some UM isolates (geomet-
ric mean parasite density, 23,078 asexual parasites/μl range,
(75-246,857) asexual parasites/μl) and anti-malarial treat-
ment before enrolment in some of the CM children,
in vitro parasite cultivation was successful among 27 of 36
isolates in the UM group and 38 of 52 isolates in the CM
group. The binding phenotypes were analysed in 65 isolates
that developed into mature forms. All but two isolates (63
of 65) bound to both CD36 and ICAM-1, and 48 isolates
bound weakly to CSPG (Table 2).
Cytoadherence levels were compared between CM
and UM samples separately to each receptor. The
binding of CM isolates to CD36 was significantly
higher (P = 0.015) than that of UM samples. However,
there was no significant difference in the binding level
to ICAM-1 (P = 0.4) or to CSPG (P = 0.1) between CM
and UM isolates Figure 1.Table 2 Receptor binding data
Cerebral malaria Uncomplicated malaria All samples
(n = 38) (n = 27) (n = 65)
CD36 350.5 (0-2552) 85.1 (0-379) 244.0 (0-2552)
ICAM-1 48.3 (0.6-215) 39.3 (0-294) 45.2 (0-294)
CSPG 11.3 (0-62) 9.6 (0-72) 10.7 (0-72)
Values are the mean number of infected erythrocytes bound (range)/mm2 to a
given receptor minus the number of infected erythrocytes bound to BSA.Transcript levels of var gene groups, DC8, and DC13
The transcription level of A, B,var2csa, var3, DC8, and
DC13 var genes was analysed by RT-qPCR in 36 UM
and 51 CM isolates. Group A, B, var2csa, var3, DC8,
and DC13 had significantly higher levels of transcription
(P <0.05) in CM isolates than in UM isolates (Table 3,
Figures 2 and 3). However, no difference in the tran-
scription level was observed between CM and UM iso-
lates when genes were targeted by A2, DBLγ4/6 and
DBLαCIDRα primer sets.
Correlation between binding phenotype and transcription
level of var genes
The relationship between binding profiles and transcrip-
tion level of var gene groups and DCs for each isolate
was examined by considering only highly transcribed
genes that were determined as ‘predominant transcripts’.
Group B var genes were the predominant transcripts
in 51% of samples. Tu value of group B var genes was
positively correlated with the binding level to CD36
(r = 0.46, P = 0.005), but not with binding to ICAM-1
(r = 0.05, P = 0.7) or CSPG (r = 0.1, P = 0.2). Group A var
genes were the predominant transcripts in 49% of samples,
and no significant correlation was observed between Tu
values and binding levels to CD36 (r = 0.2, P = 0.2), ICAM-
1 (r = 0.1, P = 0.4), or CSPG (r = -0.02, P = 0.1).
Likewise, DC8 and DC13 genes were predominant in
78.5 and 21.5% of samples, respectively. Tu values of
DC8 and DC13 were not correlated with binding the
levels to CD36(r = -0.005, [P = 0.9] and r = 0.09 [P = 0.7],
respectively), ICAM-1 (r = 0.1, [P = 0.4] and r = -0.06,
[P = 0.8], respectively) and CSPG (r = 0.05 [P = 0.7] and
r = -0.1 [P = 0.5], respectively).
Discussion
Cytoadherence of IEs to cerebral microvasculature cell
lining is considered to be the major factor in CM patho-
genesis [2,34]. This mechanism is known to be mediated
by PfEMP-1 variants expressed at the surface of IEs [35].
However, the exact ligand-receptor interactions leading
to the binding of IEs to brain microvascular endothelium
are not well understood.
To investigate the potential role of PfEMP-1 variants
in cytoadherence to host receptor, clinical isolates from
patients with cerebral or uncomplicated malaria were used
to assess the cytoadherence phenotypes to ICAM-1, CD36,
and CSPG and the transcription profiles of var genes.
The results suggest that CD36 is a common binding
receptor used by clinical isolates from both UM and
CM, in agreement with earlier findings that showed the
involvement of CD36 in cytoadherence [14,18,19]. How-
ever, contrary to the results of previous studies, CD36-
binding level was shown to be higher in isolates from
CM group than those from UM group, suggesting the
Figure 1 Binding level (number of bound IEs/mm2) of CM and UM isolates on CSPG, ICAM-1 and CD36. The difference in binding levels
to a specific receptor was tested by the Mann-Whitney U test, significant P-value is shown in the figure.
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CM. This result oppose to the likely admitted assump-
tion considering CD36 binding phenotype as common
phenotype unrelated to parasite virulence.
Conversely, in agreement with previous studies using
static binding assay [20,25], the binding level to ICAM-1
was low and comparable in CM and UM isolates.
However, a higher binding level to ICAM-1 in CM iso-
lates, as compared to that of UM isolates, was seen
under flow conditions, as probably flow assay betterTable 3 Transcript abundances of var genes from groups
A, B, var2csa, var3, DC8 and DC13
Primers ID Tu _CM median
[IQR]
Tu _UM median
[IQR]
P-value
A1 (n = xx) 1.4 [1-6.8] 1 [0-1.7] 0.01
A2 (n = xx) 1.2 [1-5.3] 1 [1-6.3] 0.8
A3 (n = xx) 19.6 [4.3-33] 6.6 [1-14.3] 0.02
B1 (n = xx) 9.3 [1-64] 1 [1-2.6] 0.001
var2 (n = xx) 1 [1-4.4] 1 [0-1] 0.001
var3 (n = xx) 17.1 [1-34] 1.4 [1-10.4] 0.008
CIDRα1.1 (DC8)
(n = xx)
2.11 [1-11.8] 1 [1-2.3] 0.02
DBLβ12 (DC8)
(n = xx)
2.8 [1-13.9] 1 [1-4.2] 0.03
DBLγ4/6 (DC8)
(n = xx)
1 [0-1] 1 [0-1] 0.4
DBLαCIDRα (DC8)
(n = xx)
0 [0-1] 0 [0-1 ] 0.4
DBLα1.7 (DC13)
(n = xx)
1.1 [1-8.1] 1 [ 0-1.5] 0.01
CIDRα1.4 (DC13)
(n = xx)
1 [1-2.2] 1 [ 0-1] 0.002
Comparisons between P. falciparum isolates from children presenting with
cerebral (CM) and uncomplicated malaria (UM) were achieved by the Mann-
Whitney U test.simulates physiological wall shear stress under which
ICAM-1 promotes IEs rolling and binding [23]. Hence,
the lower level of parasite binding to ICAM-1, as com-
pared to CD36, observed in this study may also occur
due to suboptimal interaction between ICAM-1 and IEs
resulting from conformational changes of this receptor
when immobilized on a plastic surface. Moreover, the
significantly higher MOI in CM parasites may also
endow CM group with higher number of parasites with
CD36 binding phenotype.
The development of new binding assays closely mim-
icking physiological ligand-receptor interaction will pro-
vide relevant knowledge on receptor affinity to IEs.
Moreover, it has been shown that P. falciparum isolates,
including those from CM, bind to CD36 ten-fold higher
than to ICAM-1, and that 80% of ICAM-1-selected IEs
bind to CD36, suggesting an association of CD36 with
disease pathogenesis as it facilitates the binding of a high
proportion of parasites to the endothelium in various
deep organs [36]. In addition, under flow conditions,
CD36 offers greater and more efficient adherence prop-
erty than ICAM-1 [37]. These results are in agreement
with data of this study showing a higher binding level of
IEs to CD36 than ICAM-1.
Despite the fact that CD36 is poorly expressed in brain
vascular endothelia, Turner et al. reported low but sig-
nificant association between CD36 expression and IEs
sequestration in brain vessels [38]. Moreover, IEs bind-
ing to cerebral endothelial cells may take place indirectly
through platelets accumulated in the brain vasculature
of CM patients [39]. Platelets express a high level of
CD36, which may promote IEs binding and sequestra-
tion in the brain, despite the low CD36 expression on
brain microvascular endothelium. Platelets were found
to act as a bridge between CD36-deficient brain endo-
thelium and IEs via CD36 binding. This mechanism
Figure 2 Transcript abundances of var genes from group A, B, var2csa and var3 in Plasmodium falciparum isolates from children
presenting with either cerebral (CM) or uncomplicated malaria (UM). Transcript patterns of specific var genes were compared between
groups by the Mann-Whitney U test, significant P-values are shown in the figure.
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erties, promoting CM pathogenesis [40].
PfEMP-1 variants expressed on the surface of IEs de-
termine the cytoadherence properties of parasite popula-
tions [35]. These proteins are well-described ligands, and
studies have shown that they recognize and interact with
more than one receptor independently of IEs subpopula-
tions. One PfEMP-1 variant may allow the cytoadherence
to more than one host receptor through its semi-conserved
N-terminal head structure DBL1α and CIDR1α [41].
Likewise, DBLβ2 and DBLβ3 bind ICAM-1 [42-44].
The tandem NTS-DBLα-CIDRγ of varO is essential for
IEs binding and rosette formation [45]. CIDRα1 of
DC8 and DC13 var genes is a potential ligand of endo-
thelial protein C receptor [44]. Moreover, multipleFigure 3 Transcript abundances of DC8 and DC13 targeted by CIDRα
falciparum isolates from children presenting with either cerebral (CM
between groups by the Mann-Whitney U test, significant P-values are showextracellular domains of DC8 of IT4var19 bound brain
and non brain endothelial cells [46].
In this study, the transcription of pfemp-1 variants in-
cluding groups A, B, var3, DC8, and DC13 was clearly
up-regulated in CM parasites as compared to UM iso-
lates, in agreement with previous studies [8-11], support-
ing the implication of these genes in CM pathogenesis.
var2csa is transcribed to a much higher level in isolates
from pregnant than from non-pregnant women [30].
Some CM isolates expressed var2csa at a higher level
than in UM parasites. However, binding to CSPG was
consistently very weak and similar in both UM and CM
groups, indicating that VAR2CSA does not take part in
malaria pathogenesis in children. Although VAR2CSA
expression was absent at the surface of IEs in isolates1.1, DBLβ12, DBLα1.7, and CIDRα1.4 primers in Plasmodium
) or uncomplicated malaria (UM). Transcript patterns were compared
n in the figure.
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ported to be high in these isolates [8,47].
The transcription level of group B genes positively cor-
related with the binding level of IEs to CD36, confirming
the earlier findings that parasite ligands for CD36 are
PfEMP-1 variants encoded by var genes belonging to
groups B and C through their CIDR1α domain [48,49].
Functional analysis using mutagenesis in the M2 region
of CIDR1α linked CD36 binding ability to specific CI-
DR1α residues [50]. Recombinant protein of CIDRα1.1
of DC8 also inhibits the binding of IEs to brain endothe-
lium cells, suggesting a role of this domain in binding phe-
notypes involved in cerebral malaria. However, in this
study, parasite lines that express IT4var6 and IT4var19
genes containing DC8 at high level and IT4var13 at low
level were shown to bind weakly to CD36 [13]. Other stud-
ies using parasite lines selected to express only one pfemp-1
variant are needed to demonstrate specific PFEMP-1/host
receptor combinations.
The transcription levels of DC8 and DC13 were higher
in CM isolates as compared to those in UM isolates, but
were not correlated with the binding levels to CD36,
ICAM-1, or CSPG. DC8 and DC13 are part of few genes
from groups B and A, respectively. These two domain
cassettes have been shown to mediate the binding of IEs
to EPCR [51]. Positive correlation between DC8 and 13
expression and elevated binding to EPCR could be ex-
pected in CM parasites. It is possible that the present
study did not include sufficient number of isolates ex-
pressing DC8 and DC13 and, for this reason, may have
lacked the statistical power to detect a possible correl-
ation between binding phenotypes and transcription pat-
terns. On another hand, together with PfEMP1 or alone
other parasite proteins expressed on the surface of IEs
may take part in cytoadherence mechanism making diffi-
cult to reveal such correlation.
PfEMP-1 architecture is not randomly arranged since
it has been observed that specific arrangement of CIDR
and DBL domain tandems occurs more frequently to
maintain a minimum structural function for PfEMP1
folding, export, and cytoadherence [52]. Therefore, the
correlation among transcription patterns of group B var-
iants, which are characterized by CIDR and DBL do-
mains, binding phenotype to CD36, and severity of the
disease reflects the existence of conserved phenotypes
associated with cerebral malaria.
Conclusion
A higher number of CM isolates binds more to CD36, as
compared to UM isolates, but there was no significant
difference between CM and UM isolates in the binding
levels to ICAM-1 and CSPG. CM isolates transcribed
groups A, B, var2csa, var3, DC8, and DC13 at higher
levels than UM isolates. These results support the roleof these PfEMP-1 variants in CM. Likewise, the positive
correlation between the high transcription level of group
B var genes and the increased binding of isolates from
CM patients strengthens the implication of group B var
encoding PfEMP-1 in the binding interaction with CD36
during cerebral malaria.
For its survival, the parasite has developed sophisti-
cated mechanisms to bind to host receptors and estab-
lish acute or chronic infections. Hence, the identification
of PfEMP-1 domains of group B var genes, probably
CIDR1 domains, involved in CD36 binding during cere-
bral malaria could be targeted to prevent severe and
complicated malaria.
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